よむ、つかう、まなぶ。
「日本人の食事摂取基準（2025年版）」策定検討会報告書 (134 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_44138.html |
| 出典情報 | 「日本人の食事摂取基準（2025年版）」策定検討会報告書（10／11）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
38) Bjerve KS, Thoresen L, Børsting S. Linseed and cod liver oil induce rapid growth in a 7-year-old girl with
N-3- fatty acid deficiency. JPEN J Parenter Enteral Nutr. 1988;12(5):521-525.
39) Bjerve KS. Alpha-linolenic acid deficiency in adult women. Nutr Rev. 1987;45(1):15-19.
40) Innis SM. Dietary (n-3) fatty acids and brain development. J Nutr. 2007;137(4):855-859.
41) Alexander DD, Miller PE, Van Elswyk ME, et al. A meta-analysis of randomized controlled trials and
prospective cohort studies of eicosapentaenoic and docosahexaenoic long-chain omega-3 fatty acids and
coronary heart disease risk. Mayo Clin Proc. 2017;92(1):15-29.
42) Abdelhamid AS, Brown TJ, Brainard JS, et al. Omega-3 fatty acids for the primary and secondary prevention
of cardiovascular disease. Cochrane Database Syst Rev. 2020;3(3):CD003177.
43) Naghshi S, Aune D, Beyene J, et al. Dietary intake and biomarkers of alpha linolenic acid and risk of all
cause, cardiovascular, and cancer mortality: systematic review and dose-response meta-analysis of cohort
studies. BMJ. 2021;375:n2213.
44) Wei BZ, Li L, Dong CW, et al. The relationship of omega-3 fatty acids with dementia and cognitive decline:
Evidence from prospective cohort studies of supplementation, dietary intake, and blood markers. Am J Clin
Nutr. 2023;117(6):1096-1109.
45) Burckhardt M, Herke M, Wustmann T, et al. Omega-3 fatty acids for the treatment of dementia. Cochrane
Database Syst Rev. 2016;4(4):CD009002.
46) Neuenschwander M, Barbaresko J, Pischke CR, et al. Intake of dietary fats and fatty acids and the incidence
of type 2 diabetes: A systematic review and dose-response meta-analysis of prospective observational
studies. PLoS Med. 2020;17(12):e1003347.
47) Brown TJ, Brainard J, Song F, et al. Omega-3, omega-6, and total dietary polyunsaturated fat for prevention
and treatment of type 2 diabetes mellitus: systematic review and meta-analysis of randomised controlled
trials. BMJ. 2019;366:l4697.
48) Wang T, Zhang X, Zhou N, et al. Association between omega-3 fatty acid intake and dyslipidemia: A
continuous dose-response meta-analysis of randomized controlled trials. J Am Heart Assoc.
2023;12(11):e029512.
49) Schwingshackl L, Hoffmann G. Monounsaturated fatty acids, olive oil and health status: a systematic review
and meta-analysis of cohort studies. Lipids Health Dis. 2014;13(1):154.
50) Lotfi K, Salari-Moghaddam A, Yousefinia M, et al. Dietary intakes of monounsaturated fatty acids and risk
of mortality from all causes, cardiovascular disease and cancer: A systematic review and dose-response
meta-analysis of prospective cohort studies. Ageing Res Rev. 2021;72:101467.
51) 食品安全委員会. 新開発食品評価書 食品に含まれるトランス脂肪酸. 2012.
52) Ascherio A, Katan MB, Zock PL, et al. Trans fatty acids and coronary heart disease. N Engl J
Med. 1999;340(25):1994-1998.
53) Bendsen NT, Christensen R, Bartels EM, et al. Consumption of industrial and ruminant trans fatty acids and
risk of coronary heart disease: a systematic review and meta-analysis of cohort studies. Eur J Clin Nutr.
2011;65(7):773-783.
54) Aronis KN, Khan SM, Mantzoros CS. Effects of trans fatty acids on glucose homeostasis: a meta-analysis
of randomized, placebo-controlled clinical trials. Am J Clin Nutr. 2012;96(5):1093-1099.
55) Honda T, Ohara T, Shinohara M, et al. Serum elaidic acid concentration and risk of dementia: The Hisayama
124
N-3- fatty acid deficiency. JPEN J Parenter Enteral Nutr. 1988;12(5):521-525.
39) Bjerve KS. Alpha-linolenic acid deficiency in adult women. Nutr Rev. 1987;45(1):15-19.
40) Innis SM. Dietary (n-3) fatty acids and brain development. J Nutr. 2007;137(4):855-859.
41) Alexander DD, Miller PE, Van Elswyk ME, et al. A meta-analysis of randomized controlled trials and
prospective cohort studies of eicosapentaenoic and docosahexaenoic long-chain omega-3 fatty acids and
coronary heart disease risk. Mayo Clin Proc. 2017;92(1):15-29.
42) Abdelhamid AS, Brown TJ, Brainard JS, et al. Omega-3 fatty acids for the primary and secondary prevention
of cardiovascular disease. Cochrane Database Syst Rev. 2020;3(3):CD003177.
43) Naghshi S, Aune D, Beyene J, et al. Dietary intake and biomarkers of alpha linolenic acid and risk of all
cause, cardiovascular, and cancer mortality: systematic review and dose-response meta-analysis of cohort
studies. BMJ. 2021;375:n2213.
44) Wei BZ, Li L, Dong CW, et al. The relationship of omega-3 fatty acids with dementia and cognitive decline:
Evidence from prospective cohort studies of supplementation, dietary intake, and blood markers. Am J Clin
Nutr. 2023;117(6):1096-1109.
45) Burckhardt M, Herke M, Wustmann T, et al. Omega-3 fatty acids for the treatment of dementia. Cochrane
Database Syst Rev. 2016;4(4):CD009002.
46) Neuenschwander M, Barbaresko J, Pischke CR, et al. Intake of dietary fats and fatty acids and the incidence
of type 2 diabetes: A systematic review and dose-response meta-analysis of prospective observational
studies. PLoS Med. 2020;17(12):e1003347.
47) Brown TJ, Brainard J, Song F, et al. Omega-3, omega-6, and total dietary polyunsaturated fat for prevention
and treatment of type 2 diabetes mellitus: systematic review and meta-analysis of randomised controlled
trials. BMJ. 2019;366:l4697.
48) Wang T, Zhang X, Zhou N, et al. Association between omega-3 fatty acid intake and dyslipidemia: A
continuous dose-response meta-analysis of randomized controlled trials. J Am Heart Assoc.
2023;12(11):e029512.
49) Schwingshackl L, Hoffmann G. Monounsaturated fatty acids, olive oil and health status: a systematic review
and meta-analysis of cohort studies. Lipids Health Dis. 2014;13(1):154.
50) Lotfi K, Salari-Moghaddam A, Yousefinia M, et al. Dietary intakes of monounsaturated fatty acids and risk
of mortality from all causes, cardiovascular disease and cancer: A systematic review and dose-response
meta-analysis of prospective cohort studies. Ageing Res Rev. 2021;72:101467.
51) 食品安全委員会. 新開発食品評価書 食品に含まれるトランス脂肪酸. 2012.
52) Ascherio A, Katan MB, Zock PL, et al. Trans fatty acids and coronary heart disease. N Engl J
Med. 1999;340(25):1994-1998.
53) Bendsen NT, Christensen R, Bartels EM, et al. Consumption of industrial and ruminant trans fatty acids and
risk of coronary heart disease: a systematic review and meta-analysis of cohort studies. Eur J Clin Nutr.
2011;65(7):773-783.
54) Aronis KN, Khan SM, Mantzoros CS. Effects of trans fatty acids on glucose homeostasis: a meta-analysis
of randomized, placebo-controlled clinical trials. Am J Clin Nutr. 2012;96(5):1093-1099.
55) Honda T, Ohara T, Shinohara M, et al. Serum elaidic acid concentration and risk of dementia: The Hisayama
124